Cowen & Co

Walgreens Boots Alliance Inc (NASDAQ: WBA) shares have gained 10 percent in the past six months, amid high volatility. Cowen & Co’s Charles Rhyee maintained an Outperform rating on the company, with a price target of $102. The acquisition of Rite Aid Corporation (NYSE: RAD)...

Noble Energy, Inc. (NYSE: NBL) shares are down 27 percent year-to-date, having declining steadily since mid-April. Cowen & Co’s Charles Robertson maintained an Outperform rating on the company, with a price target of $52. While the Israeli gas framework plan may be approved in...

Activision Blizzard, Inc. (NASDAQ: ATVI) shares have surged 60 percent year-to-date, and are trading close to the higher end of their 52-week range of $17.73 - $32.50. Cowen & Co’s Doug Creutz maintained an Outperform rating on the company, while raising the price target from $28...

In a report published Wednesday, Cowen & Co analyst Ritu Baral initiated coverage of Uniqure NV (NASDAQ: QURE) with an Outperform rating, citing the company's "broadly applicable, safe, proprietary baculovirus production AAV5 platform, their promising hemophilia B program and earlier programs...

A new report by Cowen focused on cigarette and soda stocks. With the major names in the two spaces already reporting Q1 earnings, analysts discussed their updated outlook for the stocks along with recent trends that investors should be watching. Volume Declines Improving In the tobacco space...

In a report published Friday, Cowen & Co analysts maintained a Market Perform rating on Dr Pepper Snapple Group Inc. (NYSE: DPS), with a price target of $80, after the company reported its 1Q15 results, Dr Pepper Snapple Group reported its core EPS at $0.81, representing 10.2 percent growth....

When Facebook Inc (NASDAQ: FB) bought Instagram for $1 billion in 2012, skeptics on Wall Street argued that the company had overpaid for a two-year old startup with only 13 employees. However, the tide has changed and now even the erstwhile skeptics are praising the "wise" decision...

Cephalon (NASDAQ: CEPH) stock rose $16.45 this morning, stopping at $75.20 a share after a hostile takeover bid of approximately $5.7 billion from Valeant Pharmaceuticals International (NYSE: VRX). Cephalon's surge is Nasdaq's biggest intraday gain since April 2000. Cephalon's surge of...

Analysts at Cowen & Co upgrade Savient Pharmaceuticals Inc (NASDAQ: SVNT) from "neutral" to "outperform." The target price for SVNT is set to $19. SVNT's shares gained 10.08% to close at $12.67 yesterday. More Analyst Ratings here

Analysts at Cowen & Co upgrade Goodrich Corporation (NYSE: GR) from "neutral" to "outperform." GR's shares gained 1.89% to close at $79.34 yesterday. More Analyst Ratings here

Analysts at Cowen & Co upgrade AnnTaylor Stores Corp (NYSE: ANN) from "underperform" to "neutral." ANN's shares lost 1.48% to close at $20.58 yesterday. More Analyst Ratings here

Bloomberg has quoted unidentified sources as saying that Genzyme (NASDAQ: GENZ) has refused the takeover offer from Sanofi-Aventis (NYSE: SNY). GENZ is, maybe, holding out for a better offer. Analyst Phil Nadeau of Cowen & Co said that it is just a matter of time, “given that Genzyme has...